Présentation
Webinar “RSV Insights: Genomic Evolution, Treatments, and Public Health Strategies”
The aim of this webinar is to provide participants with in-depth knowledge of RSV (Respiratory Syncytial Virus), including its genomic diversity, evolution, available treatments, and emerging vaccine strategies. The focus will be on how genomic data informs public health responses, the impact of RSV on vulnerable populations, and ongoing advancements in treatment and prevention. The training will also explore regulatory frameworks and public health strategies for managing RSV outbreaks.
Dates and duration:
This webinar takes place over two sessions:
- Tuesday, December 10th, from 10:00 to 13:00 (GMT+1)
- Friday, December 13th, from 14:00 to 16:30 (GMT+1).
Objectives:
Upon completing this workshop, participants will be able to:
- Understand the virology, epidemiology, and clinical impact of RSV on global health.
- Explain RSV genomic diversity, evolutionary trends, and their implications for public health.
- Use bioinformatics tools to analyze RSV genomic sequences, variants, and interpret phylogenetic data.
- Analyze genomic data to better understand RSV transmission patterns and outbreaks.
- Describe current RSV treatment options and advancements in monoclonal antibodies.
- Understand the status and challenges in developing RSV vaccines, particularly for vulnerable groups like pregnant women and the elderly.
Trainers:
- Pr. Peter Openshaw — Imperial College London
- Dr. Frédéric Lemoine — Institut Pasteur, France
- Dr. Jérome Bourret — Institut Pasteur, France
- Dr. Marie-Anne Rameix-Welti — Institut Pasteur, France
- Dr. Nick Bundle — ECDC, Sweden
- Dr. Lisa Domegan — HPSC, Ireland
Registration:
The webinar is available for free on the ECDC Virtual Academy platform (EVA), you can create an account to have acces to other webinars organized in this programme.
GenEpi-BioTrain Programme
This interdisciplinary programme, funded by ECDC, combines lectures and practical sessions delivered by multiple host institutions in order to enhance surveillance, preparedness, and readiness to respond to outbreaks.